SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (Date of earliest event reported): October 7, 1999 AMERICAN HOME PRODUCTS CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-1225 13-2526821 (State or other (Commission (IRS Employer jurisdiction of incorporation) File Number) Identification No.) Five Giralda Farms, Madison, New Jersey 07940 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: 973-660-5000 Item 5. Other Events. On October 7, 1999, American Home Products Corporation ("AHP") announced that it reached a comprehensive, national settlement to resolve litigation against AHP brought by people who used REDUX (dexfenfluramine) or PONDIMIN (fenfluramine). AHP issued a press release concerning the settlement which is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Also attached as Exhibit 99.2 is the "Memorandum of Understanding Concerning Settlement of Diet Drug Litigation" which details the terms of the settlement and is incorporated herein by reference. Item 7. Financial Statements and Exhibits. (c) Exhibits (99.1) Press Release dated October 7, 1999. (99.2) Memorandum of Understanding Concerning Settlement of Diet Drug Litigation SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AMERICAN HOME PRODUCTS CORPORATION By: /s/ Paul J. Jones Vice President and Comptroller (Duly Authorized Signatory and Chief Accounting Officer) Dated: October 8, 1999 EXHIBIT INDEX (99.1) Press Release dated October 7, 1999. (99.2) Memorandum of Understanding Concerning Settlement of Diet Drug Litigation